SHUKRA MEDTECH LIMITED (SHUKRAMED) financials

SHUKRA MEDTECH LIMITED (SHUKRAMED) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testing[1]

  • Market Cap: ₹3,639Cr.
  • Current Price: ₹82.2
  • Stock P/E: 73.3
  • ROE: 28.9%
  • ROCE: 37.0%
  • Book Value: ₹2.81
  • Dividend Yield: 0.01%
  • 52W High / Low: ₹84.8/26.3

In Sep 2026, SHUKRA MEDTECH LIMITED (SHUKRAMED) reported sales ₹44 Cr and net profit ₹16 Cr.

Annual TTM: sales ₹113 Cr, net profit ₹50 Cr.

Shareholding: Promoters 51.16% (Sep 2026), FIIs 0.43% (Sep 2026), DIIs 0.21% (Sep 2026), Public 48.20% (Sep 2026), No. of Shareholders 35,007% (Sep 2026).

SHUKRAMED quarterly results (₹ Cr.)
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales1113563962444
YoY Sales growth-44%+22%+70%+6%+270%-53%+336%+652%
Expenses7646126222
Operating Profit471-02712122
OPM %37%55%24%-7%69%11%90%50%
Other Income11121111
Interest00000000
Depreciation11111111
Profit before tax48102702021
Tax %23%29%26%-1,090%24%568%26%24%
Net Profit351220-21516
EPS in Rs0.070.120.020.050.46-0.040.340.36
Raw PDF————————
SHUKRAMED profit and loss (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales12112059753357113
Sales growth+109%-6%+83%+187%+27%-56%+74%+222%
Expenses1010185355202842
Operating Profit213519132971
OPM %13%13%14%9%26%39%51%63%
Other Income00013453
Interest00000111
Depreciation11222334
Profit before tax001420132969
Tax %82%-90%26%1%7%28%23%—
Net Profit001419102250
EPS in Rs0.000.010.020.150.420.220.501.12
Dividend Payout %0%0%10%4%6%5%2%—
SHUKRAMED balance sheet (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital222411444444
Reserves1414152147194680
Borrowings8103534521
Other Liabilities1010154517202333
Total Liabilities343635757887117178
Fixed Assets1718182020192221
CWIP2222221226
Investments00000000
Other Assets14161653566584131
Total Assets343635757887117178
SHUKRAMED cash flows (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity01183-583
Cash from Investing Activity-2-3-2-2-4-1-1-14
Cash from Financing Activity222-7512-55
Net Cash Flow0-00-0462-6
Free Cash Flow-2-2-16-1-75-13
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit25%81%38%292%64%-24%92%17%
SHUKRAMED shareholding pattern (%)
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters50.95%50.95%50.95%50.95%50.95%50.95%50.95%51.16%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.43%
DIIs0.11%0.11%0.11%0.11%0.11%0.11%0.11%0.21%
Public48.93%48.93%48.93%48.93%48.93%48.92%48.93%48.20%
No. of Shareholders17,84418,23120,33721,44125,64927,17328,38435,007
SHUKRAMED key ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days34524531813218712098148
Inventory Days1001692211392519447320
Days Payable1,16178670230327159414232
Cash Conversion Cycle-717-372-163-32-5880131236
Working Capital Days4402262785741157403352
ROCE %4%0%1%6%19%44%22%37%
SHUKRAMEDUpdated 18 Nov 2026, 1:29

Shukra Medtech Limited

Market Cap

₹3,639Cr.

Current Price

₹82.2

High / Low

₹84.8/26.3

Stock P/E

73.3

ROE28.9%
ROCE37.0%
Book Value₹2.81
Face Value₹1.00
Dividend Yield0.01%

About

Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testing[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Sep 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days737117520034524531813218712098148
Inventory Days55492112531001692211392519447320
Days Payable2911084007341,16178670230327159414232
Cash Conversion Cycle33554-112-480-717-372-163-32-5880131236
Working Capital Days7582583443794402262785741157403352
ROCE %-1%6%7%6%4%0%1%6%19%44%22%37%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SHUKRA MEDTECH LIMITED (SHUKRAMED)?

The reported market capitalisation for SHUKRA MEDTECH LIMITED (SHUKRAMED) is ₹3,639Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SHUKRAMED?

The current price shown for SHUKRA MEDTECH LIMITED (SHUKRAMED) on Fincrux is ₹82.2 with a 52-week high/low of ₹84.8/26.3.

What is the P/E ratio of SHUKRA MEDTECH LIMITED (SHUKRAMED)?

The stock P/E for SHUKRA MEDTECH LIMITED (SHUKRAMED) is 73.3 on Fincrux, with ROE at 28.9% and ROCE at 37.0%.

What were SHUKRAMED latest quarterly results?

For Sep 2026, SHUKRA MEDTECH LIMITED (SHUKRAMED) reported sales ₹44 Cr and net profit ₹16 Cr (figures in ₹ crore unless noted).

What are SHUKRAMED annual sales and net profit?

For TTM, SHUKRA MEDTECH LIMITED (SHUKRAMED) shows sales of ₹113 Cr and net profit of ₹50 Cr on the Fincrux profit & loss statement.

Who owns SHUKRA MEDTECH LIMITED (SHUKRAMED)?

Latest shareholding for SHUKRA MEDTECH LIMITED (SHUKRAMED) on Fincrux: Promoters 51.16% (Sep 2026), FIIs 0.43% (Sep 2026), DIIs 0.21% (Sep 2026), Public 48.20% (Sep 2026), No. of Shareholders 35,007% (Sep 2026).

Where can I find SHUKRA MEDTECH LIMITED (SHUKRAMED) financials?

SHUKRA MEDTECH LIMITED (SHUKRAMED) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SHUKRAMED balance sheet and cash flow?

Yes. The SHUKRA MEDTECH LIMITED (SHUKRAMED) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.